Fundraising Fox

Couragene

Edison, US · Founded 2022 · Delaware corporation · 1 known investors

Couragene develops gene and biologic therapies using novel delivery platforms.

Founders & leadership

JZ
Jiangbing ZhouNamed on SEC filing
GL
Guojuan LiaoNamed on SEC filing

Board

JWJinlin Wang
Jinlin Wangin𝕏Board directorPartner at Foothill Ventures

Investors · 1

Reported raises · per SEC filings

Form D private placements

$3.6M disclosed across 2 rounds · 2022–2024

$1MraisedMay 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mike HanrahanDirector
  • Guojuan LiaoDirector, Executive Officer, Promoter
  • Jiangbing ZhouDirector
  • Jinlin WangDirector
Offering amount
$1M
Amount sold
$1M
First sale
Apr 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.6MraisedSep 2022 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jinlin WangDirector
  • Jiangbing ZhouDirector
  • Guojuan LiaoExecutive Officer, Director, Promoter
Offering amount
$4M
Amount sold
$2.6M
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Couragene for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Couragene do?
Couragene develops gene and biologic therapies using novel delivery platforms.
Who are Couragene's investors?
Couragene's investors include Foothill Ventures.
How much funding has Couragene raised?
Couragene has disclosed $3.6M raised across 2 rounds.
Where is Couragene headquartered?
Couragene is headquartered in Edison, US.